Terms: = Skin cancer AND IKBKB, O14920, 3551, ENSG00000104365
4 results:
1. The Development of a skin cancer Classification System for Pigmented skin Lesions Using Deep Learning.
Jinnai S; Yamazaki N; Hirano Y; Sugawara Y; Ohe Y; Hamamoto R
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32751349
[TBL] [Abstract] [Full Text] [Related]
2. Polymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients.
Xin S; Zhao Y; Wang C; Huang Y; Zhuang W; Ma Y; Huang M; Xu X; Wang X; Zhang L
Pharmacogenomics J; 2020 Apr; 20(2):285-293. PubMed ID: 31664190
[TBL] [Abstract] [Full Text] [Related]
3. Optimal strength and timing of steroids in the management of erlotinib-related skin toxicities in a post-marketing surveillance study (POLARSTAR) of 9909 non-small-cell lung cancer patients.
Yamazaki N; Kiyohara Y; Kudoh S; Seki A; Fukuoka M
Int J Clin Oncol; 2016 Apr; 21(2):248-253. PubMed ID: 26499382
[TBL] [Abstract] [Full Text] [Related]
4. cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist.
Fallon MT; Storey DJ; Krishan A; Weir CJ; Mitchell R; Fleetwood-Walker SM; Scott AC; Colvin LA
Support Care Cancer; 2015 Sep; 23(9):2769-77. PubMed ID: 25680765
[TBL] [Abstract] [Full Text] [Related]